経鼻ドラッグデリバリーデバイスの世界市場レポート 2025年

経鼻ドラッグデリバリーデバイス市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.8％で、920億5,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、世界の呼吸器問題の高まり、神経疾患への応用拡大、個別化医療の動向、予防医療への取り組み、新興国での市場浸透などに起因すると考えられます。予測期間における主な動向としては、製剤技術の進歩、小児・老年用途への注力、自己投与デバイスの増加、鼻腔用粉末吸入器、生物製剤やペプチドの組み込みなどが挙げられます。

慢性疾患の罹患率の上昇が、今後数年間の経鼻ドラッグデリバリーデバイス市場の成長を牽引すると予想されます。慢性疾患は、継続的な治療を必要とする、日常生活を制限する、またはその両方を伴う、1年以上持続する疾患と定義されます。経鼻ドラッグデリバリーデバイスは、非侵襲的で効果的な薬剤投与手段を提供することで、慢性疾患の管理に使用されます。このようなデバイスは、薬剤を標的部位に直接送達することを可能にし、利便性、使いやすさ、迅速な吸収を促進します。例えば、2024年6月、英国の政府機関である国民保健サービス（NHS）は、2023年にイングランドで新たに50万人以上（549,000人）が2型糖尿病を発症するリスクがあると確認されたと報告しました。これにより、一般開業医に登録された非糖尿病性高血糖、または糖尿病予備軍の総数は3,615,330人となり、2022年の3,065,825人から大幅に増加し、20％近く上昇したことになります。したがって、慢性疾患の有病率の増加が経鼻ドラッグデリバリーデバイス市場の拡大に拍車をかけています。

また、非侵襲的ドラッグデリバリー法に対する需要の高まりも、経鼻ドラッグデリバリーデバイス市場の拡大に寄与するとみられています。非侵襲ドラッグデリバリーでは、皮膚や粘膜の貫通や切開を必要とせずに医薬品物質を体内に投与します。経鼻ドラッグデリバリーデバイスは、このアプローチを容易にし、鼻からの薬剤投与を簡単かつ効果的にする上で重要な役割を果たしています。鼻の広範な血管網を活用し、迅速な吸収を保証するこれらのデバイスは、薬物のバイオアベイラビリティを高め、患者のアドヒアランスを改善し、侵襲的な処置の必要性を排除します。例えば、2023年8月にThe Aesthetic Societyが発表したデータでは、米国における非外科的処置が大幅に増加していることが強調されており、2022年には体の輪郭形成、皮膚治療、毒素、マイクロニードルがそれぞれ31％、26％、24％、23％の成長率を示しています。その結果、非侵襲的なドラッグデリバリー方法に対する需要の高まりが、経鼻ドラッグデリバリーデバイス市場拡大の主な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界経鼻ドラッグデリバリーデバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の経鼻ドラッグデリバリーデバイス市場：成長率分析
• 世界の経鼻ドラッグデリバリーデバイス市場の実績：規模と成長, 2019-2024
• 世界の経鼻ドラッグデリバリーデバイス市場の予測：規模と成長, 2024-2029, 2034F
• 世界経鼻ドラッグデリバリーデバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の経鼻ドラッグデリバリーデバイス市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粉末供給装置
• 液体供給装置
• 加圧式定量吸入器
• その他の製品
• 世界の経鼻ドラッグデリバリーデバイス市場投与量別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単位用量
• マルチドーズ
• 世界の経鼻ドラッグデリバリーデバイス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性閉塞性肺疾患（COPD）
• 鼻炎
• 嚢胞性線維症
• 鼻づまり
• 喘息
• その他の用途
• 世界の経鼻ドラッグデリバリーデバイス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• ホームケア
• その他のエンドユーザー
• 世界の経鼻ドラッグデリバリーデバイス市場、粉末送達装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単回投与粉末デバイス
• マルチドーズパウダーデバイス
• 世界の経鼻ドラッグデリバリーデバイス市場、液体送達デバイスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単回投与液体デバイス
• 多用量液体デバイス
• 世界の経鼻ドラッグデリバリーデバイス市場加圧式定量噴霧式吸入器（pMDI）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 呼吸作動型PMDI
• 従来のpMDI
• 世界の経鼻ドラッグデリバリーデバイス市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲル送達装置
• ネブライザー
• 鼻スプレー

第7章 地域別・国別分析

• 世界の経鼻ドラッグデリバリーデバイス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の経鼻ドラッグデリバリーデバイス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経鼻ドラッグデリバリーデバイス市場：競合情勢
• 経鼻ドラッグデリバリーデバイス市場：企業プロファイル
  • Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• 3M Company
• Becton, Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• AptarGroup Inc.
• West Pharmaceutical Services Inc.
• Teleflex Incorporated
• Recipharm AB
• Nemera Development S.A.
• Consort Medical plc.
• Vectura Group plc
• Douglas Pharmaceuticals Ltd.
• Avanir Pharmaceuticals
• OptiNoset Inc.
• Flamel Technologies
• Aegis Therapeutics LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 経鼻ドラッグデリバリーデバイス市場2029：新たな機会を提供する国
• 経鼻ドラッグデリバリーデバイス市場2029：新たな機会を提供するセグメント
• 経鼻ドラッグデリバリーデバイス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Intranasal drug delivery devices are medical instruments designed to administer medications into the nasal cavity. These devices are specifically created to deliver medications directly to the highly vascularized nasal mucosa, which boasts a substantial surface area, facilitating rapid absorption of the drug into the bloodstream. Intranasal drug delivery devices are capable of delivering drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.

The primary products within the realm of intranasal drug delivery devices include powder delivery devices, liquid delivery devices, pressurized metered-dose inhalers, and other related devices. Powder delivery devices, a subtype of medical or pharmaceutical devices, are designed for administering medications in unit-dose or multi-dose forms and find applications in various medical conditions such as chronic obstructive pulmonary disease (COPD), rhinitis, cystic fibrosis, nasal congestion, asthma, among others. The end users of these devices include hospitals, clinics, homecare, and other healthcare settings.

The intranasal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides intranasal drug delivery devices market statistics, including intranasal drug delivery devices industry global market size, regional shares, competitors with a intranasal drug delivery devices market share, detailed intranasal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal drug delivery devices industry. This intranasal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $60.27 billion in 2024 to $65.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise in chronic respiratory diseases, patient preference and compliance, convenience in self-administration, pediatric applications, market expansion in allergic rhinitis treatment, wider range of indications.

The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $92.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing geriatric population, rising global respiratory issues, expanding applications in neurological disorders, personalized medicine trends, preventive healthcare initiatives, market penetration in emerging economies. Major trends in the forecast period include advances in formulation technologies, focus on pediatric and geriatric applications, rise in self-administration devices, nasal powder inhalers, incorporation of biologics and peptides.

The rising incidence of chronic diseases is anticipated to drive the growth of the intranasal drug delivery devices market in the coming years. Chronic diseases are defined as conditions lasting one year or more that require ongoing medical care, restrict daily activities, or both. Intranasal drug delivery devices are employed to manage chronic diseases by providing a non-invasive and effective means of administering medications. These devices enable medications to be delivered directly to the targeted area, offering convenience, ease of use, and promoting rapid absorption. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner to 3,615,330, marking a significant increase from 3,065,825 in 2022 and representing nearly a 20% rise. Therefore, the growing prevalence of chronic diseases is fueling the expansion of the intranasal drug delivery devices market.

The growing demand for non-invasive drug delivery methods is also expected to contribute to the expansion of the intranasal drug delivery device market. Non-invasive drug delivery involves administering pharmaceutical substances into the body without the need for skin or mucous membrane penetration or incision. Intranasal drug delivery devices play a crucial role in facilitating this approach, making it easy and effective to administer drugs through the nose. Leveraging the nose's extensive blood vessel network and ensuring fast absorption, these devices enhance drug bioavailability, improve patient adherence, and eliminate the need for invasive procedures. For example, data from The Aesthetic Society in August 2023 highlighted a significant increase in nonsurgical procedures in the U.S., with body contouring, skin treatment, toxins, and micro-needling showing growth rates of 31%, 26%, 24%, and 23%, respectively, in 2022. As a result, the growing demand for non-invasive drug delivery methods is a key driver for the expansion of the intranasal drug delivery device market.

Major pharmaceutical companies in the nasal drug delivery technology market are actively engaged in developing new and improved products to offer innovative drug administration methods and maintain their market position. For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray for delivering nasal saline and similar over-the-counter (OTC) formulations. This product, made from polyolefin materials and devoid of metal components or recycling disruptors, reduces the need for separation in recycling streams and supports a higher grade of recycled materials. Notably, APF Futurity is a highly recyclable nasal spray pump that has obtained Class AA certification from cyclos-HTP for recycling streams in Europe.

In March 2022, Sandoz AG, a Switzerland-based biopharmaceutical company under the Novartis Group, acquired Coalesce Product Development Limited for an undisclosed amount. This strategic move aims to enhance Sandoz's capabilities in inhalation drug delivery, add a commercial-stage product to its portfolio, and expedite the development and commercialization of intranasal drug delivery devices. Coalesce Product Development Limited, based in the UK, specializes in drug delivery device development, including nasal drug delivery.

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intranasal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intranasal drug delivery devices market consists of sales of nasal sprays, nasal powder devices, nasal antipsychotic medications, nasal epinephrine devices, nasal drops, and nasal inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intranasal Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intranasal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intranasal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intranasal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Powder Delivery Device; Liquid Delivery Device; Pressurized Metered-Dose Inhalers; Other Products
• 2) By Dosage: Unit-Dose; Multi-Dose
• 3) By Application: Chronic Obstructive Pulmonary Disease (COPD); Rhinitis; Cystic Fibrosis; Nasal Congestion; Asthma; Other Applications
• 4) By End User: Hospitals; Clinics; Homecare; Other End Users
• Subsegments:
• 1) By Powder Delivery Device: Single-Dose Powder Device; Multi-Dose Powder Device
• 2) By Liquid Delivery Device: Single-Dose Liquid Device; Multi-Dose Liquid Device
• 3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs; Conventional pMDIs
• 4) By Other Products: Gel Delivery Device; Nebulizers; Nasal Sprays
• Companies Mentioned: Johnson and Johnson Inc.; Merck and Co.Inc.; Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intranasal Drug Delivery Devices Market Characteristics

3. Intranasal Drug Delivery Devices Market Trends And Strategies

4. Intranasal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Intranasal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intranasal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intranasal Drug Delivery Devices Market Growth Rate Analysis
• 5.4. Global Intranasal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intranasal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intranasal Drug Delivery Devices Total Addressable Market (TAM)

6. Intranasal Drug Delivery Devices Market Segmentation

• 6.1. Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powder Delivery Device
• Liquid Delivery Device
• Pressurized Metered-Dose Inhalers
• Other Products
• 6.2. Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Unit-Dose
• Multi-Dose
• 6.3. Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Obstructive Pulmonary Disease (COPD)
• Rhinitis
• Cystic Fibrosis
• Nasal Congestion
• Asthma
• Other Applications
• 6.4. Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• Other End Users
• 6.5. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Powder Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Powder Device
• Multi-Dose Powder Device
• 6.6. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Liquid Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Liquid Device
• Multi-Dose Liquid Device
• 6.7. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Pressurized Metered-Dose Inhalers (pMDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breath-Actuated PMDIs
• Conventional pMDIs
• 6.8. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gel Delivery Device
• Nebulizers
• Nasal Sprays

7. Intranasal Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intranasal Drug Delivery Devices Market

• 8.1. Asia-Pacific Intranasal Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intranasal Drug Delivery Devices Market

• 9.1. China Intranasal Drug Delivery Devices Market Overview
• 9.2. China Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intranasal Drug Delivery Devices Market

• 10.1. India Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intranasal Drug Delivery Devices Market

• 11.1. Japan Intranasal Drug Delivery Devices Market Overview
• 11.2. Japan Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intranasal Drug Delivery Devices Market

• 12.1. Australia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intranasal Drug Delivery Devices Market

• 13.1. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intranasal Drug Delivery Devices Market

• 14.1. South Korea Intranasal Drug Delivery Devices Market Overview
• 14.2. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intranasal Drug Delivery Devices Market

• 15.1. Western Europe Intranasal Drug Delivery Devices Market Overview
• 15.2. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intranasal Drug Delivery Devices Market

• 16.1. UK Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intranasal Drug Delivery Devices Market

• 17.1. Germany Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intranasal Drug Delivery Devices Market

• 18.1. France Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intranasal Drug Delivery Devices Market

• 19.1. Italy Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intranasal Drug Delivery Devices Market

• 20.1. Spain Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intranasal Drug Delivery Devices Market

• 21.1. Eastern Europe Intranasal Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intranasal Drug Delivery Devices Market

• 22.1. Russia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intranasal Drug Delivery Devices Market

• 23.1. North America Intranasal Drug Delivery Devices Market Overview
• 23.2. North America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intranasal Drug Delivery Devices Market

• 24.1. USA Intranasal Drug Delivery Devices Market Overview
• 24.2. USA Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intranasal Drug Delivery Devices Market

• 25.1. Canada Intranasal Drug Delivery Devices Market Overview
• 25.2. Canada Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intranasal Drug Delivery Devices Market

• 26.1. South America Intranasal Drug Delivery Devices Market Overview
• 26.2. South America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intranasal Drug Delivery Devices Market

• 27.1. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intranasal Drug Delivery Devices Market

• 28.1. Middle East Intranasal Drug Delivery Devices Market Overview
• 28.2. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intranasal Drug Delivery Devices Market

• 29.1. Africa Intranasal Drug Delivery Devices Market Overview
• 29.2. Africa Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intranasal Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Intranasal Drug Delivery Devices Market Competitive Landscape
• 30.2. Intranasal Drug Delivery Devices Market Company Profiles
  • 30.2.1. Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

31. Intranasal Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. 3M Company
• 31.2. Becton, Dickinson and Company
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. AptarGroup Inc.
• 31.5. West Pharmaceutical Services Inc.
• 31.6. Teleflex Incorporated
• 31.7. Recipharm AB
• 31.8. Nemera Development S.A.
• 31.9. Consort Medical plc.
• 31.10. Vectura Group plc
• 31.11. Douglas Pharmaceuticals Ltd.
• 31.12. Avanir Pharmaceuticals
• 31.13. OptiNoset Inc.
• 31.14. Flamel Technologies
• 31.15. Aegis Therapeutics LLC

32. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market

34. Recent Developments In The Intranasal Drug Delivery Devices Market

35. Intranasal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Intranasal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intranasal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intranasal Drug Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer